Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$667M |
| 3 |
Spotify
SPOT
|
+$528M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$438M |
| 5 |
Eli Lilly
LLY
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.59B |
| 2 |
Amazon
AMZN
|
+$1.45B |
| 3 |
Merck
MRK
|
+$925M |
| 4 |
Broadcom
AVGO
|
+$765M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$672M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.59% |
| 2 | Healthcare | 7.29% |
| 3 | Financials | 7.2% |
| 4 | Industrials | 6.31% |
| 5 | Consumer Discretionary | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
PUT
Relmada Therapeutics
RLMD
$490M
| $243K | ﹤0.01% |
+75,000
| New | +$243K |
|
5202
PUT
Rollins
ROL
$17.5B
| $243K | ﹤0.01% |
+4,800
| New | +$237K |
|
5203
TScan Therapeutics
TCRX
$53.8M
| $242K | ﹤0.01% |
48,672
+20,783
| +75% | +$125K |
|
5204
Amerant Bancorp
AMTB
$1.12B
| $242K | ﹤0.01% |
+11,327
| New | +$249K |
|
5205
VinFast Auto
VFS
$7.32B
| $242K | ﹤0.01% |
63,319
+42,627
| +206% | +$169K |
|
5206
PUT
Macerich
MAC
$6.88B
| $241K | ﹤0.01% |
+13,200
| New | +$208K |
|
5207
Century Therapeutics
IPSC
$393M
| $241K | ﹤0.01% |
140,759
-237,874
| -63% | -$466K |
|
|
MRCC
5208
DELISTED
Monroe Capital Corp
MRCC
| $240K | ﹤0.01% |
+29,716
| New | +$229K |
|
|
NFGC
5209
New Found Gold
NFGC
$784M
| $240K | ﹤0.01% |
94,845
-55,598
| -37% | -$153K |
|
5210
Praxis Precision Medicines
PRAX
$10.3B
| $240K | ﹤0.01% |
4,169
-86,740
| -95% | -$4.69M |
|
5211
Alector
ALEC
$264M
| $239K | ﹤0.01% |
51,218
-105,562
| -67% | -$566K |
|
5212
CALL
SolarEdge
SEDG
$1.84B
| $238K | ﹤0.01% |
10,400
-1,800
| -15% | -$43.8K |
|
5213
Kodak
KODK
$924M
| $238K | ﹤0.01% |
50,479
-152,166
| -75% | -$792K |
|
5214
iShares US Tech Independence Focused ETF
IETC
$693M
| $238K | ﹤0.01% |
+3,040
| New | +$228K |
|
5215
Bioceres Crop Solutions
BIOX
$26.8M
| $238K | ﹤0.01% |
+30,249
| New | +$305K |
|
5216
CALL
Toast
TOST
$21.3B
| $238K | ﹤0.01% |
8,400
-17,100
| -67% | -$433K |
|
5217
Destination XL Group
DXLG
$34.3M
| $237K | ﹤0.01% |
80,606
+31,901
| +65% | +$99.3K |
|
|
SRTA
5218
Strata Critical Medical Inc
SRTA
$548M
| $237K | ﹤0.01% |
80,542
-14,035
| -15% | -$44.7K |
|
5219
CALL
Gen Digital
GEN
$17.5B
| $236K | ﹤0.01% |
8,600
-12,500
| -59% | -$321K |
|
|
5220
PUT
Gen Digital
GEN
$17.5B
| $236K | ﹤0.01% |
+8,600
| New | +$221K |
|
5221
PUT
Capricor Therapeutics
CAPR
$482M
| $236K | ﹤0.01% |
+15,500
| New | +$76.7K |
|
5222
CALL
Arch Capital
ACGL
$34.3B
| $235K | ﹤0.01% |
+2,100
| New | +$218K |
|
|
5223
PUT
Arch Capital
ACGL
$34.3B
| $235K | ﹤0.01% |
2,100
-3,000
| -59% | -$312K |
|
5224
B&G Foods
BGS
$286M
| $235K | ﹤0.01% |
26,427
-46,864
| -64% | -$397K |
|
5225
Vanguard ESG International Stock ETF
VSGX
$6.86B
| $234K | ﹤0.01% |
+3,797
| New | +$224K |
|
Similar funds
Israel Englander's Q3 2024 Portfolio in Review
As of Q3 2024, Israel Englander held 6,698 positions worth $211B, down 2.3% from $216B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander withdrew a net $20.6B in Q3 2024, closing 667 positions and reducing 2,445 holdings. Its most notable exit was WestRock Company, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Israel Englander opened a new position in Smurfit Westrock worth $94.1M.
- Israel Englander's largest Q3 2024 buy was Smurfit Westrock: 1,904,931 shares worth $94.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $1.38B increase.
- Israel Englander's biggest Q3 2024 reduction was Apple, cutting an estimated $2.59B.
- Israel Englander fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- Israel Englander's ten largest holdings make up 17% of its $211B portfolio in Q3 2024.
- Israel Englander opened 898 new positions and closed 667 in Q3 2024.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $211B.
Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.